𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Where is the room for improvement in the drug treatment of depression and anxiety?

✍ Scribed by David S. Baldwin

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
46 KB
Volume
26
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

New drug targets for depression and anxi
New drug targets for depression and anxiety: Is the peptides era arriving?
✍ David Gurwitz; Abraham Weizman πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 65 KB

## Abstract The monoamine theory of mood disorders has dominated psychiatric dogma for nearly 50 years. Recent findings about the role of brain peptides in the regulation of emotions and behavior challenge this over‐simplified theory, and are about to open the door for a new era, focused on peptide

Use of paroxetine for the treatment of d
Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review
✍ Michel Bourin πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 2 views

## Abstract Paroxetine is a potent selective serotonin reuptake inhibitor (SSRI) with indications for the treatment of depression, obsessive– compulsive disorder, panic disorder and social phobia. It is also used in the treatment of generalized anxiety disorder, post‐traumatic stress disorder, prem